000 | 01172 a2200325 4500 | ||
---|---|---|---|
005 | 20250517201727.0 | ||
264 | 0 | _c20190530 | |
008 | 201905s 0 0 eng d | ||
022 | _a1555-8576 | ||
024 | 7 |
_a10.1080/15384047.2018.1433495 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTampaki, Ekaterini Christina | |
245 | 0 | 0 |
_aCabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs. _h[electronic resource] |
260 |
_bCancer biology & therapy _c2018 |
||
300 |
_a847-849 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAnilides |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMitochondria |
650 | 0 | 4 | _aPiperidines |
650 | 0 | 4 | _aPyridines |
650 | 0 | 4 | _aQuinazolines |
650 | 0 | 4 | _aThyroid Neoplasms |
700 | 1 | _aTampakis, Athanasios | |
700 | 1 | _aDroeser, Raoul | |
700 | 1 | _aPatsouris, Efstratios | |
700 | 1 | _aKouraklis, Gregory | |
773 | 0 |
_tCancer biology & therapy _gvol. 19 _gno. 10 _gp. 847-849 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/15384047.2018.1433495 _zAvailable from publisher's website |
999 |
_c28084961 _d28084961 |